Cardiac Dysfunction in Spontaneous Bacterial Peritonitis: A Manifestation of Cirrhotic Cardiomyopathy?

Hepatology

Volumn 38, Issue 5, 2003, Pages 1089-1091

  Lee, Samuel S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PERITONITIS; CARDIOMYOPATHY; CIRRHOTIC CARDIOMYOPATHY; DISEASE ASSOCIATION; EDITORIAL; ELECTROPHYSIOLOGY; HEART DISEASE; HEART FUNCTION; HEART OUTPUT; HUMAN; LIVER CIRRHOSIS; PRIORITY JOURNAL;

EID: 0142182794     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50489     Document Type: Editorial

References (27)

1. Kowalski HJ, Abelmann WH. Cardiac output in Laennec cirrhosis. J Clin Invest 1953;32:1356-1358.
2. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. HEPATOLOGY 1994;20:1359-1363.
3. Gould L, Shariff M, Zahir M, Di Lieto M. Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop. J Clin Invest 1969;19;312-321.
4. Gerbes AL, Remien J, Jungst D, Sauerbruch T, Paumgartner G. Evidence for the down-regulation of β-adrenoreceptors in cirrhotic patients with severe ascites. Lancet 1986;1:1409-1410.
5. Caramelo C, Fernandes-Munoz D, Santos JC, Blanchart A, Rodrigues-Puyol D, Lopez-Novoa JM, et al. Effect of volume expansion on hemodynamics, capillary permeability, and renal function in conscious, cirrhotic rats. HEPATOLOGY 1986;6:129-134.
6. Lee SS, Marty J, Mantz J, Samain E, Braillon A, Lebrec D. Desensitization of myocardial β-adrenergic receptors in cirrhotic rats. HEPATOLOGY 1990; 12:481-485.
7. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. HEPATOLOGY 1996;24:451-459.
8. Blendis L, Wong F. Is there a cirrhotic cardiomyopathy? Am J Gastroenterol 2000;95:3026-3028.
9. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002;87:9-15.
10. Bernardi M, Calandra S, Colantoni A, Trevisani F, Raimondo ML, Sica G, Schepis F, et al. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity and etiology of the disease, and possible pathogenetic factors. HEPATOLOGY 1998;27:28-34.
11. Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl 2000;6(Suppl 1):S44-S52.
12. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Moller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol 2002;36:513-520.
13. Ward CA, Ma Z, Lee SS, Giles WR. Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis. Am J Physiol 1997;273: G537-G544.
14. Finucci G, Desideri A, Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol 1996;31:279-284.
15. Wong F, Liu P, Lily L, Bomzon A, Blendis L. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci 1999;97:259-267.
16. Inserte J, Perello A, Agullo L, Ruiz-Meana M, Schluter KD, Escalona N, Graupera M, et al. Left ventricular hypertrophy in rats with biliary cirrhosis. HEPATOLOGY 2003;38:589-598.
17. Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin and tacrolimus. Liver Transpl 2002;8:690-700.
18. Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, Planas R, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839-1847.
19. Merli M, Valeriano V, Funaro S, Attili AF, Masini A, Efrati C, De CS, et al. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 2002;97:142-148.
20. Ruiz-del-Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, Albillos A, et al. Systemic, renal and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. HEPATOLOGY 2003;38:1210-1218.
21. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003;112:460-467.
22. Krishnagopalan S, Kumar A, Parillo J, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opinion Crit Care 2002;8:376-388.
23. Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology 2000; 118:937-944.
24. Liu H, Lee SS. TNFα in cirrhotic cardiomyopathy [abstract]. J Hepatol 2002;36(Suppl 1):11.
25. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-274.
26. Huang Ti. Huang Ti Nei Ching Wei Zhu (The Yellow Emperor's Treatise of Medicine), c. 2700 B.C., Chapter 3, section 8.
27. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. HEPATOLOGY 1988;8:1151-1157.